<- Go home

Added to YB: 2020-09-16

Pitch date: 2020-09-16

ILMN:US [bullish]

Illumina, Inc.

-56.07%

current return

Author Info

No bio for this author

Company Info

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Market Cap

$18.4B

Pitch Price

$307.01

Price Target

N/A

Dividend

N/A

EV/EBITDA

15.81

P/E

27.05

EV/Sales

4.60

Sector

Life Sciences Tools and Services

Category

N/A

Show full summary:
Illumina, Inc. ILMN:US

A summary for this pitch has not been created yet.

Read full article (0 min)